Prot # P58/07CL/ST/09/02: Phase II, Multi-Centre, Randomised, Double-Blind, Placebo-Controlled, Parallel Group Study to Investigate the Efficacy, Safety and Tolerability of Cogane™ (PYM50028), A Novel, Orally Active Neurotrophic Factor Inducer, in Male an

Project: Research project

Project Details

StatusFinished
Effective start/end date3/2/11 → 3/2/14

Funding

  • ICON Clinical Research, LLC (Prot# P58/07CL/ST/09/02 // Prot# P58/07CL/ST/09/02)
  • Phytopharm plc (Prot# P58/07CL/ST/09/02 // Prot# P58/07CL/ST/09/02)